about
Development of an improved methodology to detect infectious airborne influenza virus using the NIOSH bioaerosol samplerGene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Can biowarfare agents be defeated with light?Development of Prototype Filovirus Recombinant Antigen ImmunoassaysNeurological aspects of chemical and biological terrorism: guidelines for neurologists.Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entryIdentification of a small-molecule entry inhibitor for filoviruses.An upstream open reading frame modulates ebola virus polymerase translation and virus replication.Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicineAn optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media.Antivirals and antiviral strategies.Filovirus-like particles as vaccines and discovery tools.Development of a model for marburgvirus based on severe-combined immunodeficiency mice.Development of treatment strategies to combat Ebola and Marburg viruses.Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection.Protection against filovirus infection: virus-like particle vaccines.Protection against lethal challenge by Ebola virus-like particles produced in insect cells.Single nanoparticle detectors for biological applicationsNo exit: targeting the budding process to inhibit filovirus replication.Ebola virus outbreak, updates on current therapeutic strategies.Development of Small-Molecule Antivirals for Ebola.Understanding the dynamics of Ebola epidemics.Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors.High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus diseaseZMappTM Reinforces the Airway Mucosal Barrier Against Ebola Virus.A guided tour through the antiviral drug field
P2860
Q23912922-538F9E4A-582A-4913-BE55-755104F7CD3FQ25256700-8C58D194-DC2A-43E1-9B98-A9494B34A0B7Q28396096-2A9D3C0C-9D81-4815-B8C0-3652A249C174Q28607807-742E7005-5EEF-464A-B088-2A48B7062CAFQ30235079-4AED1C9C-259A-427E-BA11-197A5F08BB82Q33655087-0E289396-AA51-47F6-92A4-352E98BF895FQ33768646-F263FC85-0A69-4981-9131-43F08C4F12EFQ33785133-ABCD9A35-BB29-4EB6-9E9F-DC51E3920332Q33804801-BB3B9BD2-BBB0-44A6-8854-1E71969E4FFCQ34574867-9385C5B2-B0B2-4F53-8DA3-497DAF9BF1F4Q34664182-D35CFFD2-84F2-4A63-ABF4-E7C27D2A0ECDQ34676027-0A3235B6-A23B-4FE0-89A7-8D9F80AC8069Q35048254-717F99C6-5729-4A16-B61E-D5E98DF7F283Q35069581-C0B4CF2F-00FA-4A11-8D20-41D1707E8D66Q35889586-62A220FB-6DBF-484A-B6F3-033A02B7ACB0Q36198685-06E0F3B9-B51C-4C0D-ABB6-65F06FAB9633Q36310674-6FDF94EB-234A-41D7-A69C-4910F0855F80Q36379341-C9070E69-A8B7-4D16-A7D1-2EA03BD8462CQ36789989-21D95647-5DB4-4944-B8DA-5FCACD30AC21Q37130463-6E11D08D-1042-439C-9C04-460D00710C14Q37131622-08172FE5-EFD2-4ECB-A886-4E9AE691C9B9Q37137311-C8D7F4AB-789A-48C0-8487-B934C10F9A3DQ37359650-924AB87F-BAD7-4EAB-B901-86390BC066A5Q38473251-55A7494C-3B8D-4A82-90AF-EB0F0C8E210AQ38546746-B8CF92A5-4C2F-4F3B-AE46-1ABF984F93CFQ38879030-E77FA481-9035-4FC5-A769-491C03BA1539Q39141291-B3A26671-5401-4A35-B952-93E02D97A674Q39259533-BB8951BD-A40E-42D7-A002-787A6AB4FB63Q40145853-CBE836AC-039C-4FF7-8CCA-A9801415D8BAQ40256210-6CB13540-69E1-4FDB-B785-75392459D460Q47159908-322B2A24-7BBC-4423-9277-E810FDC22DAEQ54107825-E8D8DB18-4181-4E5F-846D-3D14AB354E1BQ56786373-3F3E4BAD-5092-4DA6-80B5-60FF10D29056
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Defense against filoviruses used as biological weapons.
@ast
Defense against filoviruses used as biological weapons.
@en
type
label
Defense against filoviruses used as biological weapons.
@ast
Defense against filoviruses used as biological weapons.
@en
prefLabel
Defense against filoviruses used as biological weapons.
@ast
Defense against filoviruses used as biological weapons.
@en
P1433
P1476
Defense against filoviruses used as biological weapons.
@en
P2093
P356
10.1016/S0166-3542(02)00200-0
P577
2003-01-01T00:00:00Z